TP53 and cancer: For example, it was described that both wild type and mutant p53 proteins show kinetics of aggregation and fibrillar morphology that resemble those of classical amyloidogenic proteins, as αS [89,90], suggesting that p53-mutant cancers may be a class of protein aggregation diseases.